Rondeau E, Paillard F, Peraldi M N, Violet I, Tasse S, Dussaule J C, Ardaillou R, Sraer J D
Service de Néphrologie, Hôpital Tenon, Paris, France.
Kidney Int. 1993 Jul;44(1):165-72. doi: 10.1038/ki.1993.227.
To determine the renal functional reserve in renal transplant recipients, we measured the glomerular filtration rate by inulin clearance and the renal plasma flow by PAH clearance before and during an amino acid infusion (Totamine, 6 to 8 mg/kg/min for 90 to 120 min) in 18 transplanted patients with stable renal function. To test the role of the renin-angiotensin system on the renal functional reserve, we performed a crossover placebo-controlled randomized trial of acute blockade of the renin-angiotensin system by injection of perindoprilat (2 mg i.v.), an inhibitor of angiotensin converting enzyme before amino acid infusion, each patient being studied twice at seven day intervals. Amino acid infusion induced a time-dependent increase in the glomerular filtration rate (P = 0.04), whether or not the renin-angiotensin system was blocked. Maximal increases were from 49.1 +/- 4.1 to 58.9 +/- 5.4, mean +/- SE (18.5%), in control conditions and from 52.4 +/- 5.6 to 62.1 +/- 5.5 ml/min/1.73 m2 (19.7%) after perindoprilat. The increase in glomerular filtration rate was less pronounced in patients taking cyclosporin A than in patients treated with steroid and azathioprine. Amino acid infusion also induced a significant and time-dependent increase (15.2 to 20.2%) in the renal plasma flow (P < 0.01) whether or not perindoprilat had been given. Furthermore, perindoprilat alone increased renal plasma flow by 13.6%, and this effect seemed additive with that of amino acids. Perindoprilat injection decreased filtration fraction (from 0.20 +/- 0.01 to 0.19 +/- 0.01). This parameter returned to basal values after amino acid infusion (0.20 +/- 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)
为了确定肾移植受者的肾功储备,我们在18例肾功能稳定的移植患者中,于输注氨基酸(托他命,6至8毫克/千克/分钟,持续90至120分钟)前及输注期间,通过菊粉清除率测定肾小球滤过率,通过对氨基马尿酸清除率测定肾血浆流量。为了检验肾素-血管紧张素系统对肾功储备的作用,我们进行了一项交叉安慰剂对照随机试验,在输注氨基酸前,通过静脉注射培哚普利拉(2毫克)急性阻断肾素-血管紧张素系统,培哚普利拉是一种血管紧张素转换酶抑制剂,每名患者每隔7天接受两次研究。无论肾素-血管紧张素系统是否被阻断,输注氨基酸均导致肾小球滤过率随时间增加(P = 0.04)。在对照条件下,最大增幅从49.1±4.1增至58.9±5.4,平均±标准误(18.5%),在注射培哚普利拉后,从52.4±5.6增至62.1±5.5毫升/分钟/1.73平方米(19.7%)。服用环孢素A的患者肾小球滤过率的增加不如接受类固醇和硫唑嘌呤治疗的患者明显。无论是否给予培哚普利拉,输注氨基酸还导致肾血浆流量显著且随时间增加(15.2%至20.2%)(P < 0.01)。此外,单独使用培哚普利拉可使肾血浆流量增加13.6%,且这种作用似乎与氨基酸的作用相加。注射培哚普利拉降低了滤过分数(从0.20±0.01降至0.19±0.01)。输注氨基酸后该参数恢复至基础值(0.20±0.01)。(摘要截断于250字)